Shuffle for fans
Chatbot

trialsitenews's podcast

News • Health-and-fitness

TrialSite News Podcast Series is a segment where we talk with patients, doctors, CROs, nurses, clinical researchers and investigators, and clinical site representatives, to give you a full view of healthcare. We want our audience to know the good and the bad happening with clinical trials andRead more

Popular episodes

The Media's Viral Lie about Ivermectin Overdoses & Horse Medicine: Dr. Kory Responds | Interview

Sep 23 • 26:07

In the last few weeks, the mainstream media ran with stories about Ivermectin, most noticeably referring to it as "horse medicine" or "horse dewormer" while, for some reason, leaving out the fact that Ivermectin is a WHO essential medicine for HUMANS....

Kelly McKee from Medidata talks transforming the patient clinical trial experience

Sep 2 • 13:02

CATalyst | Indian Bar Association Serve Legal Notice on WHO's chief scientist Dr. Soumya Swaminathan

Jun 10 • 16:50
Join the Conversation! | https://trialsitenews.com/ In the first edition of CATalyst, Shabnam Palesa Mohamed engages Advocate Dipali Ohja (IBA), Dr Pierre Kory (FLCCC), and Dr Tess Lawrie (EBMC) about the Indian Bar Association's decision to issue legal notice on WHO chief scientist, Dr Soumya Swaminathan. The 51 page notice, served 25th of May, claims as its legal basis a...

Ralph Lorigo Talks NY Court Rulings Over Ivermectin Use In Covid-19 Treatment | Interview

May 5 • 19:36

We sit down with Ralph Lorigo, of the Law Office of Ralph C. Lorigo to discuss NY court cases regarding Ivermectin and Covid-19....

Shabnam Palesa Mohamed, discusses state of Ivermectin in South Africa | Podcast

Mar 24 • 26:54

Shabnam Palesa Mohamed: Activist. journalist, mediator (LLB). Founder of SAHARI and THJ CEO, discusses state of Ivermectin in South Africa. We discuss the twists and turns of the legality issues of the drug, to a campaign to bring awareness through-out the country and beyond....

Dr. Kedar discusses Covid-19 impact on bringing research to rural communities

Mar 17 • 21:46

We talk with Dr. Kedar about rural research initiatives and the impact Covid-19 has had in bringing advanced research to them. Dr. Kedar specializes in autoimmune diseases that effect the musculoskeletal system, such as rheumatism, arthritis, and other disorders of the joints, muscles and ligaments....

Melanie Rice: Patient Suffering from MS discusses her experience with the disease

Mar 10 • 15:52

Today we’ll be touching on a tough subject, Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord....

Sam Searcy Talks Accelerating The Clinical Trials Process With Cloud-Based Service Providers

Mar 3 • 11:52

We sit down with Sam Searcy to talk about his Company Clinistart, and innovative cloud-based service providers designed to accelerate clinical trial site activation and study start up. The goal: accelerate each step of the clinical trials process to accelerate the availability of medicines sooner for patients....

Dr. John Boockvar Of Lenox Hill Hospital Talks New Surgical Technique To Treat Glioblastoma

Feb 24 • 11:06

We sit down for an interview with Dr. John Boockvar, vice chair of neurosurgery at Lenox Hill Hospital, who started a first-in-human clinical research study involving a new surgical technique to treat glioblastoma multiforme (GBM) - the most aggressive form of brain cancer....

Stuttering and the Speak Freely Study | Interview With Dr. Gerald Maguire of UC Riverside

Feb 17 • 18:37

An interview with Dr. Gerald Maguire about the Phase 2 Speak Freely Study, which is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, exploratory study in adult subjects with childhood onset fluency disorder. Essentially a study directed at adults with stuttering....

Check out similar podcasts

THE MEM
exqwip
Where There's Smoke
Brett Gajda and Nick Jaworski
TwitterBlogCareersPress KitCommunity GuidelinesTerms of ServicePrivacy Policy
© 2021 Akora Labs, Inc.